SUPPORT for Patients and Communities Reauthorization Act of 2025

Bill Number: H.R. 2483
Origin Chamber: House
Congress: 119th Congress, Session 1
Policy Area: Health
Status: Became Law
Became Law: Public Law 119-44
Latest Action: 2025-12-01: Became Public Law No: 119-44.
Last Updated: 2026-07-11T02:58:23Z

AI-Generated Summary

## Purpose of the Legislation

This Act reauthorizes and updates programs originally established under the SUPPORT for Patients and Communities Act of 2018. Its primary goal is to continue and strengthen federal efforts in preventing, treating, and supporting recovery from opioid use disorder and related substance use issues through 2030.

## Key Provisions Outlined

The legislation is organized into four titles:

Title I—Prevention: Updates grants for prenatal health, infection monitoring, overdose prevention, fetal alcohol spectrum disorder (FASD) education and services, prescription drug monitoring programs (PDMPs), first responder training, child trauma initiatives, suicide prevention lifeline cybersecurity, and state/tribal opioid response grants. It also adds guidance on at-home drug disposal and assessments of opioid drugs.
Title II—Treatment: Reauthorizes residential treatment for pregnant and postpartum women, expands access to addiction medicine providers, supports mental health training grants, loan repayment for treatment workforce, trauma-informed care task forces, and guidance on serious mental illness. It includes reviews of buprenorphine-naloxone scheduling and references to overdose reversal agents.
Title III—Recovery: Enhances building communities of recovery, peer support centers, comprehensive opioid recovery centers, youth prevention programs, workforce support grants (CAREER Act), and economic impact addressing. It also improves access to funding opportunity information.
Title IV—Miscellaneous Matters: Modifies rules for pharmacy delivery of certain controlled substances and updates required training for prescribers of controlled substances.

Funding authorizations are generally extended from fiscal years 2019–2023 to 2026–2030, with some increased amounts and new reporting or evaluation requirements.

## Significant Changes to Existing Law Introduced

Extends and adjusts authorization periods and funding levels across multiple Public Health Service Act sections and the original SUPPORT Act.
Expands first responder training and prevention programs to cover substances beyond opioids, including synthetic opioids and emerging drugs.
Adds new requirements for cybersecurity protections and incident reporting for the 988 National Suicide Prevention Lifeline.
Introduces or expands programs for FASD prevention, intervention, and services delivery, including state/tribal capacity building.
Modifies eligibility and application processes for grants, such as allowing consortia of local educational agencies and adding transportation support in workforce programs.
Updates prescriber training qualifications to include additional professional organizations and podiatric medicine.
Requires reviews of opioid analgesic drugs, FASD activities, and state block grant use for early psychosis.
Removes or streamlines certain prior requirements, such as specific subsections in grant programs.

## Potential Impacts on Government Agencies, Citizens, or International Relations

Government Agencies: Increases responsibilities for the Department of Health and Human Services (HHS), Substance Abuse and Mental Health Services Administration (SAMHSA), Food and Drug Administration (FDA), and Drug Enforcement Administration (DEA) in grant administration, reporting, guidance development, and regulatory reviews. States and Indian Tribes gain flexibility in program implementation but face new evaluation and cybersecurity obligations.
Citizens: Enhances access to prevention, treatment, and recovery services for individuals with substance use disorders, pregnant/postpartum women, youth, and those affected by trauma or FASD. May improve outcomes through expanded workforce support, peer programs, and overdose reversal tools.
International Relations: No provisions directly address international matters.

## Main Stakeholders Affected

Federal agencies including HHS, SAMHSA, FDA, DEA, and the Centers for Disease Control and Prevention.
State and tribal governments, local educational agencies, and nonprofit organizations.
Healthcare providers, addiction medicine specialists, first responders, mental health professionals, and peer support specialists.
Patients and families impacted by opioid use disorder, substance misuse, FASD, trauma, or serious mental illness.
Educational institutions, recovery communities, and workforce development entities.

## Notable Legal, Constitutional, or Political Implications

Builds on the framework of the 2018 SUPPORT Act by extending its core authorizations without introducing major new constitutional questions.
Emphasizes evidence-based and trauma-informed approaches, with requirements for evaluations and public input in certain areas.
Includes technical amendments to align terminology (e.g., capitalization of "Tribes") and clarifies that provisions supplement, rather than replace, existing federal laws on privacy and reporting.
Political focus remains on domestic public health responses to the ongoing opioid crisis, with no alterations to federalism structures beyond grant flexibility for states and tribes.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Guthrie, Brett [R-KY-2]

Cosponsors (1)

Rep. Pettersen, Brittany [D-CO-7]

Recent Actions

2025-12-01: Became Public Law No: 119-44.
2025-12-01: Became Public Law No: 119-44
2025-12-01: Signed by President.
2025-12-01: Signed by President.
2025-11-25: Presented to President.
2025-11-25: Presented to President.
2025-09-19: Message on Senate action sent to the House.
2025-09-18: Passed Senate without amendment by Unanimous Consent. (consideration: CR S6712)
2025-09-18: Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
2025-09-18: Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
2025-09-18: Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
2025-06-05: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2025-06-04: Motion to reconsider laid on the table Agreed to without objection.
2025-06-04: On passage Passed by the Yeas and Nays: 366 - 57 (Roll no. 151). (Roll call 151)
2025-06-04: Passed/agreed to in House: On passage Passed by the Yeas and Nays: 366 - 57 (Roll no. 151). (Roll call 151)

Bill Versions

SUPPORT for Patients and Communities Reauthorization Act of 2025 — issued 2025-06-04 — PDF (60 pages)
SUPPORT for Patients and Communities Reauthorization Act of 2025 — issued 2025-09-20 — PDF (23 pages)
SUPPORT for Patients and Communities Reauthorization Act of 2025 — issued 2025-03-31 — PDF (51 pages)
SUPPORT for Patients and Communities Reauthorization Act of 2025 — issued 2025-06-05 — PDF (58 pages)
SUPPORT for Patients and Communities Reauthorization Act of 2025 — issued 2025-05-29 — PDF (52 pages)